These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12473647)

  • 1. LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer.
    Abdollahi A; Pisarcik D; Roberts D; Weinstein J; Cairns P; Hamilton TC
    J Biol Chem; 2003 Feb; 278(8):6041-9. PubMed ID: 12473647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions.
    Abdollahi A
    J Cell Physiol; 2007 Jan; 210(1):16-25. PubMed ID: 17063461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mouse Zac1 locus: basis for imprinting and comparison with human ZAC.
    Smith RJ; Arnaud P; Konfortova G; Dean WL; Beechey CV; Kelsey G
    Gene; 2002 Jun; 292(1-2):101-12. PubMed ID: 12119104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zac1 (Lot1), a potential tumor suppressor gene, and the gene for epsilon-sarcoglycan are maternally imprinted genes: identification by a subtractive screen of novel uniparental fibroblast lines.
    Piras G; El Kharroubi A; Kozlov S; Escalante-Alcalde D; Hernandez L; Copeland NG; Gilbert DJ; Jenkins NA; Stewart CL
    Mol Cell Biol; 2000 May; 20(9):3308-15. PubMed ID: 10757814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOT1 (ZAC1/PLAGL1) as member of an imprinted gene network does not harbor Silver-Russell specific variants.
    Jäger S; Schönherr N; Spengler S; Ranke MB; Wollmann HA; Binder G; Eggermann T
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):555-9. PubMed ID: 19694203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human HYMAI/PLAGL1 differentially methylated region acts as an imprint control region in mice.
    Arima T; Yamasaki K; John RM; Kato K; Sakumi K; Nakabeppu Y; Wake N; Kono T
    Genomics; 2006 Nov; 88(5):650-8. PubMed ID: 16928428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein.
    Abdollahi A; Bao R; Hamilton TC
    Oncogene; 1999 Nov; 18(47):6477-87. PubMed ID: 10597250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the methylation-sensitive promoter of the imprinted ZAC gene supports its role in transient neonatal diabetes mellitus.
    Varrault A; Bilanges B; Mackay DJ; Basyuk E; Ahr B; Fernandez C; Robinson DO; Bockaert J; Journot L
    J Biol Chem; 2001 Jun; 276(22):18653-6. PubMed ID: 11297535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of the imprinted gene ZAC by DNA methylation is an early event in the progression of human ovarian cancer.
    Kamikihara T; Arima T; Kato K; Matsuda T; Kato H; Douchi T; Nagata Y; Nakao M; Wake N
    Int J Cancer; 2005 Jul; 115(5):690-700. PubMed ID: 15751035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters.
    Valleley EM; Cordery SF; Bonthron DT
    Hum Mol Genet; 2007 Apr; 16(8):972-81. PubMed ID: 17341487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both gene deletion and promoter hyper-methylation contribute to the down-regulation of ZAC/PLAGL1 gene in gastric adenocarcinomas: a case control study.
    Li Z; Ding Y; Zhu Y; Yin M; Le X; Wang L; Yang Y; Zhang Q
    Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):744-50. PubMed ID: 25091631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imprinting at the PLAGL1 domain is contained within a 70-kb CTCF/cohesin-mediated non-allelic chromatin loop.
    Iglesias-Platas I; Court F; Camprubi C; Sparago A; Guillaumet-Adkins A; Martin-Trujillo A; Riccio A; Moore GE; Monk D
    Nucleic Acids Res; 2013 Feb; 41(4):2171-9. PubMed ID: 23295672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma.
    Lemeta S; Jarmalaite S; Pylkkänen L; Böhling T; Husgafvel-Pursiainen K
    J Neuropathol Exp Neurol; 2007 Sep; 66(9):860-7. PubMed ID: 17805016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck.
    Koy S; Hauses M; Appelt H; Friedrich K; Schackert HK; Eckelt U
    Head Neck; 2004 Apr; 26(4):338-44. PubMed ID: 15054737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes.
    Kamiya M; Judson H; Okazaki Y; Kusakabe M; Muramatsu M; Takada S; Takagi N; Arima T; Wake N; Kamimura K; Satomura K; Hermann R; Bonthron DT; Hayashizaki Y
    Hum Mol Genet; 2000 Feb; 9(3):453-60. PubMed ID: 10655556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation.
    Valleley EM; Cordery SF; Carr IM; MacLennan KA; Bonthron DT
    Genes Chromosomes Cancer; 2010 May; 49(5):480-6. PubMed ID: 20175198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.